The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Open accessAbstract
BACKGROUND: The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS: After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS: In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prediabetes is linked with increased risks of major manifestations of vascular disease, but it remains unclear whether the elevated disease risks depend on development of clinical diabetes.84,85”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“A recent individual-level evidence from prospective studies suggests that fasting hyperglycaemia (figure 3), postload glucose, and A1c are all robust predictors of vascular mortality86,88,89 and, according to multivariable adjusted analyses, these associations are independent of vascular risk factors, such as obesity, blood pressure, triglyceride and lipoproteins.84,85,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“The study found that a 50-year-old with T2DM died, on average, 6 years earlier than an individual without T2DM, with about 40% of the difference in survival attributable to excess non-vascular deaths.95”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“Aside from CV death, results from the Emerging Risk Factors Collaboration, including 820 900 people, demonstrate that T2DM is independently associated with increased risk of death from several cancers (i.e.liver, pancreas, ovary, colorectum, lung, bladder, and breast), renal and liver disease, pneumonia and other infectious diseases, mental and nervous system disorders, non-hepatic digestive dis”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“These are consistent with downward secular trends in cardiovascular disease and improvements in mortality and are in line with previously reported estimates of the reduction in life expectancy due to diabetes [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Self-citationMortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,010
Fasting Glucose Level and the Risk of Incident Atherosclerotic Cardiovascular Diseases
Park, C., Güallar, E., Linton, J. A., Lee, D., Jang, Y., Son, D. K., Han, E., Baek, S. J., Yun, Y. D., Jee, S. H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1577 · Cited by 175
Lowe, G. D. O., Woodward, M., Hillis, G. S., Rumley, A., Li, Q., Harrap, S. B., Marre, M., Hamet, P., Patel, A. A., Poulter, N. R., et al. (2013) · Diabetes · doi:10.2337/db12-1625 · Cited by 169
Butler, J., HAMO, C. E., Filippatos, G. S., Pocock, S., Bernstein, R. A., Brueckmann, M., Cheung, A. K., George, J. T., Green, J. B., Januzzi, J. L., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.933 · Cited by 167
Revisiting the links between glycaemia, diabetes and cardiovascular disease
Sattar, N. (2013) · Diabetologia · doi:10.1007/s00125-012-2817-5 · Cited by 163
Rozanski, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.047 · Cited by 168
Survival after postoperative morbidity: a longitudinal observational cohort study
Moonesinghe, R., Harris, S. K., Mythen, M. G., Rowan, K., Haddad, F. S., Emberton, M., & Grocott, M. P. W. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu224 · Cited by 162
Health risk behaviours and allostatic load: A systematic review
Suvarna, B., Suvarna, A., Phillips, R., Juster, R., McDERMOTT, B. M., & Sarnyai, Z. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.020 · Cited by 181
Diabetes in South-East Asia: An update
Ramachandran, A., Snehalatha, C., & Ronald, C. W. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.011 · Cited by 161
Hypoxia-inducible factors and diabetes
Gunton, J. E. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137556 · Cited by 159
Diabetes and its comorbidities—where East meets West
Kong, A. P. S., Xu, G., Brown, N., So, W., Ronald, C. W., & Chan, J. C. N. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.102 · Cited by 161
Prediabetes and associated disorders
Buysschaert, M., Medina, J. L., Bergman, M., Shah, A., & Lonier, J. (2014) · Endocrine · doi:10.1007/s12020-014-0436-2 · Cited by 164
Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
Jurjus, A. R., Eid, A., Kattar, S. A., Zeenny, M. N., Geagea, A. G., Haydar, H., Hilal, A., Oueidat, D., Matar, M., Tawilah, J., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.11.002 · Cited by 157
Seufert, J., & Gallwitz, B. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12251 · Cited by 156
Diabetes with early kidney involvement may shorten life expectancy by 16 years
Wen, C. P., Ch, C., Tsai, M. K., Lee, J. H., Lu, P. J., Tsai, S. P., Chen, C., Chen, C. H., Kao, C. W., Tsao, C. K., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.030 · Cited by 161
Deng, Y., Lu, L., Aponte, L., Angelidi, A. M., Novak, V., Karniadakis, G. E., & Mantzoros, C. S. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00480-x · Cited by 152
Psychosocial Factors in Diabetes and Cardiovascular Risk
Hackett, R. A., & Steptoe, A. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0771-4 · Cited by 152
The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
Avogaro, A., & Fadini, G. P. (2014) · Diabetes Care · doi:10.2337/dc14-0865 · Cited by 154
Metformin and cancer: An existing drug for cancer prevention and therapy (Review)
Zi, F., Zi, H., Li, Y., He, J., Shi, Q., & Cai, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7412 · Cited by 156
The Safety of Incretin-Based Therapies—Review of the Scientific Evidence
Drucker, D. J., Sherman, S. I., Bergenstal, R. M., & Buse, J. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0599 · Cited by 149
Rehkopf, D. H., Needham, B. L., Lin, J., Blackburn, E. H., Zota, A. R., Wojcicki, J. M., & Epel, E. S. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002188 · Cited by 155
Steinberg, G. R., & Schertzer, J. D. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.11 · Cited by 150
Gerstein, H. C., Miller, M. E., Ismail‐Beigi, F., Largay, J. F., McDonald, C. G., Lochnan, H. A., & Booth, G. L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60611-5 · Cited by 149
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
Schwalm, J.-D., McKee, M., Huffman, M. D., & Yusuf, S. (2016) · Circulation · doi:10.1161/circulationaha.115.008721 · Cited by 155
Kalyani, R. R., Tra, Y., Yeh, H., Egan, J. M., Ferrucci, L., & Brancati, F. L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12204 · Cited by 147
Wang, T., Lu, J., Su, Q., Chen, Y., Bi, Y., Mu, Y., Chen, L., Hu, R., Tang, X., Yu, X., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2499 · Cited by 145
Albiero, M., Poncina, N., Tjwa, M., Ciciliot, S., Menegazzo, L., Ceolotto, G., de Kreutzenberg, S. V., Moura, R., Giorgio, M., Pelicci, P. G., et al. (2013) · Diabetes · doi:10.2337/db13-0894 · Cited by 149
Chen, S. C.-C., Tsai, S. P., Jhao, J.-Y., Jiang, W.-K., Tsao, C. K., & Chang, L.-Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04631-7 · Cited by 148
Sex differences in the risk of vascular disease associated with diabetes
de Ritter, R., de Jong, M., Vos, R. C., Kallen, C., Sep, S. J. S., Woodward, M., Stehouwer, C. D. A., Bots, M. L., & Peters, S. A. E. (2020) · Biology of Sex Differences · doi:10.1186/s13293-019-0277-z · Cited by 154
Schwingshackl, L., Strasser, B., & Hoffmann, G. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000331214 · Cited by 147
Lepper, P. M., Ott, S. R., Nüesch, E., von Eynatten, M., Schumann, C., Pletz, M. W., Mealing, N. M., Welte, T., Bauer, T. T., Suttorp, N., et al. (2012) · BMJ · doi:10.1136/bmj.e3397 · Cited by 152
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Sabatino, J., Rosa, S. D., Tammè, L., Iaconetti, C., Sorrentino, S., Polimeni, A., Mignogna, C., Amorosi, A., Spaccarotella, C., Yasuda, M., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01040-5 · Cited by 151
Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling
Funai, K., Song, H., Li, Y., Lodhi, I. J., Wei, X., Yoshino, J., Coleman, T., & Semenkovich, C. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65726 · Cited by 142
Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
Alicic, R. Z., Johnson, E. J., & Tuttle, K. R. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.002 · Cited by 147
Balena, R., Hensley, I. E., Miller, S., & Barnett, A. H. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12025 · Cited by 143
Sattar, N. A., Preiss, D., Robinson, J. G., Djedjos, C. S., Elliott, M., Somaratne, R. M., Wasserman, S. M., & Raal, F. J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00003-6 · Cited by 143
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
Wainwright, P., & Byrne, C. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030367 · Cited by 145
Benefits of flu vaccination for persons with diabetes mellitus: A review
Goeijenbier, M., van Sloten, T. T., Slobbe, L., Mathieu, C., van Genderen, P. J. J., BEYER, W. E. P., & Osterhaus, A. D. M. E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.095 · Cited by 143
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 144
Diabetes and Hepatitis C: A Two-Way Association
Hammerstad, S. S., Grock, S., Lee, H. J., Hasham, A., Sundaram, N. K., & Tomer, Y. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00134 · Cited by 145
Cefalu, W. T., Buse, J. B., Tuomilehto, J. O., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 148
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
Olmo-García, M. I. D., & Merino-Torres, J. F. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4020492 · Cited by 149
Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?
Hulme, K. D., Gallo, L. A., & Short, K. R. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00861 · Cited by 143
Mortality Trends Among People With Type 1 and Type 2 Diabetes in Australia: 1997–2010
Harding, J. L., Shaw, J. E., Peeters, A., Guiver, T., Davidson, S., & Magliano, D. J. (2014) · Diabetes Care · doi:10.2337/dc14-0096 · Cited by 158
Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth
Nomiyama, T., Kawanami, T., Irie, S., Hamaguchi, Y., Terawaki, Y., Murase, K., Tsutsumi, Y., Nagaishi, R., Tanabe, M., Morinaga, H., et al. (2014) · Diabetes · doi:10.2337/db13-1169 · Cited by 138
Castro, M., Carnicero, J. A. C., García‐García, F. J., Walter, S., Morley, J. E., Rodríguez‐Artalejo, F., Sinclair, A. J., & Rodríguez‐Mañas, L. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.07.013 · Cited by 136
von Frankenberg, A. D., Reis, A. F., & Gerchman, F. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000316 · Cited by 147
Diabetes and cancer: Associations, mechanisms, and implications for medical practice
Xu, C. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.372 · Cited by 138
Mirani, M., Favacchio, G., Carrone, F., Betella, N., Biamonte, E., Morenghi, E., Mazziotti, G., & Lania, A. G. (2020) · Diabetes Care · doi:10.2337/dc20-1340 · Cited by 137
Su, J., Li, Z., Huang, M., Wang, Y., Yang, T., Ma, M., Ni, T., Pan, G., Lai, Z., Li, C., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01523-7 · Cited by 138
The role of patient education in the prevention and management of type 2 diabetes: an overview
Coppola, A., Sasso, L., Bagnasco, A., Giustina, A., & Gazzaruso, C. (2015) · Endocrine · doi:10.1007/s12020-015-0775-7 · Cited by 151
Time-Dependent Risk of Cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults
Dankner, R. S., Boffetta, P., Balicer, R. D., Keinan‐Boker, L., Sadeh, M., Berlin, A., Olmer, L., Goldfracht, M., & Freedman, L. S. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv290 · Cited by 133
From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
Chan, J. C. N., Lim, L., Luk, A. O. Y., Ozaki, R., Kong, A. P. S., Ronald, C. W., So, W., & Lo, S. (2019) · Diabetes Care · doi:10.2337/dci19-0003 · Cited by 137
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
Renehan, A. G., Yeh, H., Johnson, J. A., Wild, S. H., Gale, E. A. M., & Møller, H. (2012) · Diabetologia · doi:10.1007/s00125-012-2526-0 · Cited by 132
Global trend of diabetes mortality attributed to vascular complications, 2000–2016
Ling, W., Huang, Y., Huang, Y., Fan, R., Sui, Y., & Zhao, H.-L. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01159-5 · Cited by 155
Gkrania‐Klotsas, E., Langenberg, C., Sharp, S. J., Luben, R., Khaw, K., & Wareham, N. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit083 · Cited by 130
Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
Brownrigg, J. R. W., de Lusignan, S., McGovern, A. P., Hughes, C., Thompson, M. M., Ray, K. K., & Hinchliffe, R. J. (2014) · Heart · doi:10.1136/heartjnl-2014-305657 · Cited by 131
Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Chang, C., Lin, J., Wu, L., Lai, M., & Chuang, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1162 · Cited by 129
Sasso, F. C., Pafundi, P. C., Simeon, V., Nicola, L. D., Chiodini, P., Galiero, R., Rinaldi, L., Nevola, R., Salvatore, T., Sardu, C., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01343-1 · Cited by 130
Karnevi, E., Said, K., Andersson, R., & Rosendahl, A. H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-235 · Cited by 99
Habib, S. L., & Rojna, M. (2013) · ISRN Oncology · doi:10.1155/2013/583786 · Cited by 131
Norhammar, A., Bodegård, J., Nyström, T., Thuresson, M., Eriksson, J. W., & Nathanson, D. (2016) · Diabetologia · doi:10.1007/s00125-016-3971-y · Cited by 129
Pandey, A., Patel, K. V., Bahnson, J. L., Gaussoin, S. A., Martin, C. K., Balasubramanyam, A., Johnson, K. C., McGuire, D. K., Bertoni, A. G., Kitzman, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044865 · Cited by 127
Type 2 diabetes and cardiovascular disease in women
Norhammar, A., & Schenck-Gustafsson, K. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2694-y · Cited by 128
Dehal, A. N., Newton, C. C., Jacobs, E. J., Patel, A. V., Gapstur, S. M., & Campbell, P. T. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0303 · Cited by 131
Quality of life in people with diabetes: a systematic review of studies in Iran
Kiadaliri, A., Najafi, B., & Mirmalek-Sani, M. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-54 · Cited by 125
Yamagishi, S., Fukami, K., & Matsui, T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0176-5 · Cited by 127
for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Penno, G., Solini, A., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Lamacchia, O., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4691-2 · Cited by 129
Dong, J.-Y., Zhang, L., Zhang, Y.-H., & Qin, L.-Q. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100540x · Cited by 124
Diabetes and cancer I: risk, survival, and implications for screening
Onitilo, A. A., Engel, J. M., Glurich, I., Stankowski, R. V., Williams, G. M., & Doi, S. A. R. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9972-3 · Cited by 127
Jansen, J., Rosenkranz, E., Overbeck, S., Warmuth, S., Mocchegiani, E., Giacconi, R., Weiskirchen, R., Karges, W., & Rink, L. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.008 · Cited by 124
Halvorsen, R. E., Elvestad, M., Molin, M., & Aune, D. (2021) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000218 · Cited by 134
HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes
Wang, N., Ma, H., Li, J., Meng, C., Zou, J., Wang, H., Liu, K., Liu, M., Xiao, X., Zhang, H., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.10.010 · Cited by 124
Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration
Fadini, G. P., Ferraro, F., Quaini, F., Asahara, T., & Madeddu, P. R. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0052 · Cited by 123
Current therapeutic interventions in the glycation pathway: evidence from clinical studies
Engelen, L., Stehouwer, C. D. A., & Schalkwijk, C. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12058 · Cited by 126
Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
Alicic, R. Z., Neumiller, J. J., Johnson, E. J., Dieter, B. P., & Tuttle, K. R. (2019) · Diabetes · doi:10.2337/dbi18-0007 · Cited by 125
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Goodarzi, M. O., & Rotter, J. I. (2020) · Circulation Research · doi:10.1161/circresaha.119.316065 · Cited by 119
Is Hepatitis C Virus Carcinogenic?
Lemon, S. M., & McGivern, D. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.045 · Cited by 129
Decker, S. L., Kostova, D., Kenney, G. M., & Long, S. K. (2013) · JAMA · doi:10.1001/jama.2013.7106 · Cited by 120
Baum, A., Scarpa, J. R., Bruzelius, E., Tamler, R., Basu, S., & Faghmous, J. H. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30176-6 · Cited by 125
Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target
Zhou, H., Li, N., Yuan, Y., Jin, Y., Guo, H., Deng, W., & Tang, Q. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0698-6 · Cited by 122
Diabetic lung disease: fact or fiction?
Kolahian, S., Leiss, V., & Nürnberg, B. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09516-w · Cited by 123
Wu, H., Lau, E. S. H., Ronald, C. W., Kong, A. P. S., Wild, S. H., Goggins, W. B., Chow, E., So, W., Chan, J. C. N., & Luk, A. O. Y. (2020) · Diabetologia · doi:10.1007/s00125-019-05074-7 · Cited by 121
Fadini, G. P., Bonora, B. M., Zatti, G., Vitturi, N., Iori, E., Marescotti, M. C., Albiero, M., & Avogaro, A. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0529-3 · Cited by 126
Palazzuoli, A., & Iacoviello, M. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10238-6 · Cited by 128
Scott, R. A., Freitag, D. F., Li, L., Chu, A. Y., Surendran, P., Young, R., Grarup, N., Stančáková, A., Chen, Y., Varga, T. V., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3744 · Cited by 115
Kanasaki, K. (2018) · Clinical Science · doi:10.1042/cs20180031 · Cited by 121
Ihenacho, U. K., Nolden, K. A., Harwig, M. C., Widlansky, M. E., & Hill, R. B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.660095 · Cited by 117
Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus
White, W. B., Pratley, R. E., Fleck, P. R., Munsaka, M., Hisada, M., Wilson, C., & Menon, V. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12093 · Cited by 117
Kromhout, D., Geleijnse, J. M., de Goede, J., Griep, L. M. O., Mulder, B. J. M., de Boer, M., Deckers, J. W., Boersma, E. H., Zock, P. L., & Giltay, E. J. (2011) · Diabetes Care · doi:10.2337/dc11-0896 · Cited by 116
High intakes of protein and processed meat associate with increased incidence of type 2 diabetes
Ericson, U., Sonestedt, E., Gullberg, B., Hellstrand, S., Hindy, G., Wirfält, E., & Orho‐Melander, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512003017 · Cited by 119
Remschmidt, C., Wichmann, O., & Harder, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0295-6 · Cited by 115
“An impaired immune response has been hypothesized to be responsible for an increased risk of infection [8-10] as well as infection-related complications in patients with diabetes [11,12].”
BackgroundFisher, E. B., Chan, J. C. N., Nan, H., Sartorius, N., & Oldenburg, B. F. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70009-5 · Cited by 120
Li, M., Su, L., Liang, B., Tan, J., Chen, Q., Long, J., Xie, J., Wu, G., Yan, Y., Guo, X., et al. (2013) · International Journal of Endocrinology · doi:10.1155/2013/753150 · Cited by 118
Aune, D., Schlesinger, S., Neuenschwander, M., Feng, T., Janszky, I., Norat, T., & Ríboli, E. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.07.005 · Cited by 118
Abu-Ashour, W., Twells, L., Valcour, J., Randell, A., Donnan, J., Howse, P., & Gamble, J.-M. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000336 · Cited by 113
Wang, Y., Wang, P., Wang, B., Fu, Z., Zhao, W., & Yan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095485 · Cited by 113
The Treatment of Type 2 Diabetes
Pfeiffer, A. F. H., & Klein, H. H. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0069 · Cited by 136
Linking the Metabolic State and Mitochondrial DNA in Chronic Disease, Health, and Aging
Picard, M. A., & Turnbull, D. M. (2013) · Diabetes · doi:10.2337/db12-1203 · Cited by 119
Harding, J. L., Shaw, J. E., Peeters, A., Davidson, S., & Magliano, D. J. (2016) · Diabetes Care · doi:10.2337/dc15-2308 · Cited by 124
Obesity and type 2 diabetes: which patients are at risk?
Garber, A. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01536.x · Cited by 114
Metadata
- Authors
- The Emerging Risk Factors Collaboration
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- The Emerging Risk Factors Collaboration
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-03-03
- Volume
- 364
- Issue
- 9
- Pages
- 829-841
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4109980
- OpenAlex
- W2126919962
- Semantic Scholar
- a89247dcde559e5839cef19b130059e2ad9abc75
- Cited by
- 2,726
- References
- 40
- Citations by year
- 2026: 102 · 2025: 138 · 2024: 186 · 2023: 151 · 2022: 200 · 2021: 225 · 2020: 218 · 2019: 182 · 2018: 190 · 2017: 203 · 2016: 190 · 2015: 196 · 2014: 193 · 2013: 145 · 2012: 147
- FWCI
- 141.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/013/25942, RG/08/014, PG/09/002/26056, RG/07/008/23674, RG/08/014/24067)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc085086-022, UL1TR000062, n01hc55222-0-0-0)
- Economic and Social Research Council (ES/G007438/1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081)
- National Center for Research Resources (UL1RR025014)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, fasting blood glucose, hyperglycemia, cause-specific mortality, cancer mortality, vascular death, premature mortality, liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, lung cancer, breast cancer, renal disease mortality, infectious disease mortality, intentional self-harm, chronic obstructive pulmonary disease, mortality risk factors
- MeSH terms
- Blood Glucose, Cause of Death, Diabetes Mellitus, Female, Humans, Hyperglycemia, Life Expectancy, Male, Middle Aged, Risk, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
